Share
𝕏 Facebook LinkedIn

Liver lesion conspicuity during real-time MR-guided radiofrequency applicator placement using spoiled gradient echo and balanced steady-state free precession imaging.

PAPER pubmed Journal of magnetic resonance imaging : JMRI 2014 Other Effect: unclear Evidence: Low

Abstract

PURPOSE: To retrospectively evaluate the conspicuity of liver lesions in a fluoroscopic spoiled gradient echo (GRE) and a balanced steady-state free precession (SSFP) magnetic resonance imaging (MRI) sequence. MATERIALS AND METHODS: In all, 103 patients with hepatocellular carcinomas (HCC) (41) or liver metastases (67) were treated using MR-guided radiofrequency ablation in a wide-bore 1.5 T scanner. A multislice real-time spoiled GRE sequence allowing for a T1 weighting (T1W) and a balanced SSFP sequence allowing for a T2/T1W contrast were used for MR guidance. The contrast-to-noise-ratio (CNR) of the lesions was calculated and lesion conspicuity was assessed retrospectively (easily detectable / difficult to detect / not detectable). RESULTS: HCC was easily detectable in 33/52% (GRE/SSFP), difficult to detect in 30/18%, and not detectable in 37/30% of the cases. Mean CNR varied widely (9.1 for GRE vs. 16.4 for SSFP). Liver metastases were easily detectable in 58/41% (GRE/SSFP), difficult to detect in 14/21%, and not detectable in 28/38% of the cases. Mean CNR for liver metastases was 11.5 (GRE) vs. 12.7 (SSFP). Twenty percent of all lesions could not be detected with either of the MR fluoroscopy sequences. CONCLUSION: MR fluoroscopy using GRE and SSFP contrast enabled real-time detectability of 80% of the liver lesions.

AI evidence extraction

At a glance
Study type
Other
Effect direction
unclear
Population
Patients with hepatocellular carcinoma (HCC) or liver metastases undergoing MR-guided radiofrequency ablation in a 1.5 T MRI scanner
Sample size
103
Exposure
Evidence strength
Low
Confidence: 74% · Peer-reviewed: yes

Main findings

In 103 patients treated with MR-guided radiofrequency ablation, lesion detectability differed by sequence (spoiled GRE vs balanced SSFP) and lesion type. Overall, 20% of lesions could not be detected with either MR fluoroscopy sequence, implying 80% real-time detectability across sequences.

Outcomes measured

  • Liver lesion conspicuity (easily detectable / difficult to detect / not detectable)
  • Contrast-to-noise ratio (CNR)

Limitations

  • Retrospective evaluation
View raw extracted JSON
{
    "study_type": "other",
    "exposure": {
        "band": null,
        "source": null,
        "frequency_mhz": null,
        "sar_wkg": null,
        "duration": null
    },
    "population": "Patients with hepatocellular carcinoma (HCC) or liver metastases undergoing MR-guided radiofrequency ablation in a 1.5 T MRI scanner",
    "sample_size": 103,
    "outcomes": [
        "Liver lesion conspicuity (easily detectable / difficult to detect / not detectable)",
        "Contrast-to-noise ratio (CNR)"
    ],
    "main_findings": "In 103 patients treated with MR-guided radiofrequency ablation, lesion detectability differed by sequence (spoiled GRE vs balanced SSFP) and lesion type. Overall, 20% of lesions could not be detected with either MR fluoroscopy sequence, implying 80% real-time detectability across sequences.",
    "effect_direction": "unclear",
    "limitations": [
        "Retrospective evaluation"
    ],
    "evidence_strength": "low",
    "confidence": 0.7399999999999999911182158029987476766109466552734375,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "MRI",
        "MR fluoroscopy",
        "spoiled gradient echo",
        "balanced SSFP",
        "liver lesions",
        "hepatocellular carcinoma",
        "liver metastases",
        "MR-guided radiofrequency ablation",
        "contrast-to-noise ratio",
        "lesion conspicuity"
    ],
    "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.